BCMU
BEAT

BlueCrest Capital Management (UK)’s BioTelemetry, Inc. BEAT Stock Holding History

BlueCrest Capital Management (UK)’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-18,470
Closed -$186K – 823
2014
Q1 		$186K Buy
+18,470
New +$170K 0.01% 468

Other funds holding BEAT

CPIM
Columbia Partners Investment Management Alexandria, Virginia $257M AUM 8.17% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SC
Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

BlueCrest Capital Management (UK)'s BEAT Position: Q2 2014 in Review

BlueCrest Capital Management (UK) sold out of BioTelemetry, Inc. (BEAT) in Q2 2014, closing a stake of 18,470 shares — an estimated $186K sold.

BlueCrest Capital Management (UK) first reported a position in BEAT in Q1 2014 and held it in 1 quarter. The position peaked at $186K in Q1 2014. 93 funds tracked by Wall St. Rank hold BEAT as of Q2 2014.

  • BlueCrest Capital Management (UK) reported no remaining BioTelemetry, Inc. position as of Q2 2014 after selling out during the quarter.
  • BlueCrest Capital Management (UK) sold 18,470 BioTelemetry, Inc. shares in Q2 2014, an estimated $186K.
  • BlueCrest Capital Management (UK) first reported a position in BioTelemetry, Inc. in Q1 2014 and held it in 1 quarter.
  • BlueCrest Capital Management (UK)'s BioTelemetry, Inc. position peaked at $186K in Q1 2014.
  • 93 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2014.

Based on BlueCrest Capital Management (UK)'s 13F filing for Q2 2014, filed 15 Aug 2014.